PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

Florian Lordick(Technical University of Munich), Katja Ott(Technical University of Munich), Bernd‐Joachim Krause(Technical University of Munich), Wolfgang Weber(Technical University of Munich), Karen Becker(Technical University of Munich), H. J. Stein(Paracelsus Medical University), Sylvie Lorenzen(Technical University of Munich), Tibor Schuster(Technical University of Munich), Hinrich Wieder(Klinikum rechts der Isar), Ken Herrmann(Klinikum rechts der Isar), Rainer Bredenkamp(Klinikum rechts der Isar), Heinz Höfler(Klinikum rechts der Isar), U. Fink(Technical University of Munich), Christian Peschel(Technical University of Munich), Markus Schwaiger(Klinikum rechts der Isar), J. R. Siewert(Technical University of Munich)
The Lancet Oncology
August 11, 2007
Cited by 807

Abstract


Related Papers

No related papers found

Powered by citation graph analysis